Status :Actively Recruiting
Phase 2 Clinical Study
Insurance not needed
Hero participant
Free health checks
Throughout the study
Only 2 injections
Week 0 and Week 12

New treatment study for adults with triglycerides 500 or above. See if you qualify today

Help scientists study a new injectable treatment option for people with very high triglycerides (blood fats). Qualifying participants in our clinical study may receive compensation of up to $1,933 for their time.

2
injections
up to $1,933
for time and travel
Free
All Health Checks
CHECK IF YOU QUALIFY

Is this the right study for you

We're looking for people who meet certain criteria to join this important clinical study. Here are some simple guidelines to help you decide.

You are 18 years old or older
All participants must be at least 18 years old at the time of enrollment in the study.
Your blood fats (triglycerides) are very high
Your fasting blood triglycerides are 500 mg/dL or higher, confirmed at two separate visits
Your weight is in a healthy range
Your Body Mass Index (BMI) is between 18.5 and 45 kg/m²
Your medications are on a stable dose
If you are currently taking lipid-lowering or other related medications such as statins, fibrates, or omega-3 fatty acids, you have been on a consistent, unchanged dose for the required period prior to joining the study.
You are in stable health condition
You should be in good overall health to participate in the study.
No major heart event in the past 3 months
You have not experienced a heart attack, stroke, unstable angina, coronary bypass surgery, or any other major cardiac procedure within the past 3 months prior to joining the study.
Change compensation
Your participation matters, and it's compensated. Qualifying participants in our clinical study may receive compensation of up to $1,933. Compensation varies based on study visit and completion requirements.
Part-time commitment
No health insurance needed
EXPLORE YOUR NEXT STEP

Built on science. Backed by a global sponsor.

We know taking part in a clinical study is a big decision, here's what makes this study important, and what you need to know.

Sponsored by Eli Lilly and Company
Eli Lilly is a leading global pharmaceutical company dedicated to developing innovative treatments that improve health outcomes worldwide.
Rigorously reviewed
This study has been reviewed and approved by an independent ethics committee, ensuring the safety and welfare of all participants.
Researched with rigor & purpose
Built on years of careful research and scientific discovery, this study explores new possibilities for managing high blood fats.
Understanding a new therapy
This study is looking at a new injectable treatement medicine to help manage very high blood fats Understanding how it works could help many.
Completely voluntary
You may leave this study at any time, for any reason. Your participation is entirely voluntary and you can withdraw without penalty.
Access to the best care
Study participants receive study-related medical care from experienced research teams at no cost throughout the duration of the trial.
Quick Eligibility Check

5 Quick Questions

No medical knowledge needed. Just answer honestly, it takes about 2 minutes and there's no commitment.

Basic Information
US Flag+1
YOUR CLINICAL TRIAL JOURNEY

A simple journey from start to finish

Every step is guided. You'll always feel supported, informed, and cared for - from day one.

STEP 1

Quick Questionnaire

Answer a few simple questions online to see if you may qualify for the study.

STEP 2

Visit with the team

Meet with a qualified research team who will review your health and confirm eligibility.

STEP 3

Treatment Period

If eligible, you'll begin the study treatment phase with regular check-ins and monitoring.

STEP 4

Final Evaluation

Complete your final visit and receive compensation for your valuable participation.

DecenTrialz

Finding the Right clinical trial shouldn't feel overwhelming.

DecenTrialz helps you discover clinical trials that fit your condition, location, and needs without the guesswork. We combine smart technology with real human support so you can understand your options, check eligibility, and take the next step with confidence. No medical jargon. No endless searching. Just a clear path forward.

Platform overview illustration

Ready to find out if you qualify?

It takes less than 2 minutes, and there's no obligation. Qualifying participants can start their journey toward better health and get compensated.

Frequently Asked Questions

Everything you need to know about this triglycerides study.

Triglycerides are a type of fat in your blood. Your body converts extra calories into triglycerides and stores them in fat cells, then releases them later as energy between meals. The American Heart Association uses these fasting categories: Normal (below 150 mg/dL), Borderline High (150 to 199 mg/dL), High (200 to 499 mg/dL), and Very High (500 mg/dL or above). This study is enrolling adults whose fasting triglycerides are confirmed at 500 mg/dL or higher at two separate visits.

Common causes include Type 2 diabetes, obesity, an underactive thyroid, kidney disease, excessive alcohol use, and a diet high in carbohydrates, processed foods, or added sugars. Inherited (genetic) conditions and certain medications can also raise triglyceride levels. This Phase 2 study is testing a new injectable treatment to see how it works for adults whose triglycerides remain at 500 mg/dL or higher despite stable use of standard lipid-lowering medications such as statins, fibrates, or omega-3 fatty acids.

No. Hypertriglyceridemia means you have too many triglycerides in your blood. Hypercholesterolemia means you have too much cholesterol. Both are lipid conditions and many people have both at once, but they involve different fats and are treated differently. Severe hypertriglyceridemia refers to fasting triglycerides of 500 mg/dL or higher. This study focuses specifically on adults with severe hypertriglyceridemia, not on cholesterol management.

People with severe hypertriglyceridemia face an increased risk of acute pancreatitis, an inflammation of the pancreas that requires medical care. Very high triglycerides are also linked to heart disease. Many adults achieve normal levels with diet, exercise, and medicine, but some still struggle to reach safe levels. This study is exploring whether a new injectable treatment can help adults whose triglycerides remain very high despite their current therapy.

The study involves only 2 injections, given at Week 0 and Week 12, with health checks throughout the study period. Insurance is not required. Qualifying participants may receive compensation of up to $1,933 for their time and travel. To start, answer the 5 short questions on this page. If your answers suggest you may qualify, a registered nurse will follow up within 3 business days. Participation is voluntary and you can withdraw at any time.

Call+1 872 339 0186